{"id":"https://openalex.org/W4414366356","doi":"https://doi.org/10.1158/2767-9764.30162532","title":"Table 3 from Prognostic Impact of Immune-Related Adverse Events on Combination Immune Checkpoint/Tyrosine Kinase Inhibition for Metastatic Renal Cancer","display_name":"Table 3 from Prognostic Impact of Immune-Related Adverse Events on Combination Immune Checkpoint/Tyrosine Kinase Inhibition for Metastatic Renal Cancer","publication_year":2025,"publication_date":"2025-09-19","ids":{"openalex":"https://openalex.org/W4414366356","doi":"https://doi.org/10.1158/2767-9764.30162532"},"language":"en","primary_location":{"id":"doi:10.1158/2767-9764.30162532","doi":"https://doi.org/10.1158/2767-9764.30162532","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.30162532","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/2767-9764.30162532","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025066095","display_name":"Bunpei Isoda","orcid":"https://orcid.org/0009-0008-6483-3032","observed_orcids":["https://orcid.org/0009-0008-6483-3032"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bunpei Isoda","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0008-6483-3032","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069098509","display_name":"Masanobu Shiga","orcid":"https://orcid.org/0000-0001-8610-0149","observed_orcids":["https://orcid.org/0000-0001-8610-0149"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Masanobu Shiga","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8610-0149","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003028689","display_name":"Shuya Kandori","orcid":"https://orcid.org/0000-0003-4621-8470","observed_orcids":["https://orcid.org/0000-0003-4621-8470"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shuya Kandori","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4621-8470","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110113174","display_name":"Shigeru Takahashi","orcid":"https://orcid.org/0009-0001-5673-3559","observed_orcids":["https://orcid.org/0009-0001-5673-3559"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shota Takahashi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0001-5673-3559","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111247404","display_name":"Akifumi Omiya","orcid":"https://orcid.org/0009-0009-1397-9792","observed_orcids":["https://orcid.org/0009-0009-1397-9792"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Akifumi Omiya","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0009-1397-9792","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069048786","display_name":"Tomoki Ishida","orcid":"https://orcid.org/0009-0009-1261-0766","observed_orcids":["https://orcid.org/0009-0009-1261-0766"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tomoki Ishida","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0009-1261-0766","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113280511","display_name":"Kotoe Matsuda","orcid":"https://orcid.org/0009-0004-6941-0750","observed_orcids":["https://orcid.org/0009-0004-6941-0750"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kotoe Matsuda","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0004-6941-0750","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006883712","display_name":"Hiromichi Sakurai","orcid":"https://orcid.org/0009-0004-1254-0001","observed_orcids":["https://orcid.org/0009-0004-1254-0001"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hiromichi Sakurai","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0004-1254-0001","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042897629","display_name":"Bryan James Mathis","orcid":"https://orcid.org/0000-0002-9879-8289","observed_orcids":["https://orcid.org/0000-0002-9879-8289"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bryan J. Mathis","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9879-8289","affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Ken Tanaka","orcid":"https://orcid.org/0000-0003-4350-4156","observed_orcids":["https://orcid.org/0000-0003-4350-4156"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ken Tanaka","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4350-4156","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077668498","display_name":"Manabu Komine","orcid":"https://orcid.org/0009-0005-5184-1250","observed_orcids":["https://orcid.org/0009-0005-5184-1250"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Manabu Komine","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0005-5184-1250","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075529362","display_name":"Masahiro Iinuma","orcid":"https://orcid.org/0000-0003-1777-1525","observed_orcids":["https://orcid.org/0000-0003-1777-1525"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Masahiro Iinuma","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1777-1525","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069020781","display_name":"Akira Joraku","orcid":"https://orcid.org/0000-0001-8589-9737","observed_orcids":["https://orcid.org/0000-0001-8589-9737"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Akira Joraku","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8589-9737","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027612764","display_name":"Hiromitsu Negoro","orcid":"https://orcid.org/0000-0003-1144-2755","observed_orcids":["https://orcid.org/0000-0003-1144-2755"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hiromitsu Negoro","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1144-2755","affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Masakazu Tsutsumi","orcid":"https://orcid.org/0009-0000-6556-2862","observed_orcids":["https://orcid.org/0009-0000-6556-2862"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Masakazu Tsutsumi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0000-6556-2862","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059104414","display_name":"Takamitsu Inoue","orcid":"https://orcid.org/0000-0002-1362-4344","observed_orcids":["https://orcid.org/0000-0002-1362-4344"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Takamitsu Inoue","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1362-4344","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114376114","display_name":"Jun Miyazaki","orcid":"https://orcid.org/0000-0002-3618-0432","observed_orcids":["https://orcid.org/0000-0002-3618-0432"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jun Miyazaki","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3618-0432","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5071455815","display_name":"Hiroyuki Nishiyama","orcid":"https://orcid.org/0000-0001-7423-596X","observed_orcids":["https://orcid.org/0000-0001-7423-596X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hiroyuki Nishiyama","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7423-596X","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8407999873161316,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8407999873161316,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.15299999713897705,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11297","display_name":"Ferroptosis and cancer prognosis","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.8410000205039978},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.8840000033378601},{"id":"https://openalex.org/keywords/metastatic-renal-cell-carcinoma","display_name":"metastatic renal cell carcinoma","score":0.8309999704360962},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.8420000076293945},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.7940000295639038},{"id":"https://openalex.org/keywords/patient-characteristics","display_name":"patient characteristics","score":0.7540000081062317},{"id":"https://openalex.org/keywords/prognostic-impact","display_name":"prognostic impact","score":0.7860000133514404}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.871999979019165},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.7401000261306763},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6152999997138977},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6079999804496765},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6028000116348267},{"id":"https://openalex.org/C2781068499","wikidata":"https://www.wikidata.org/wiki/Q3242950","display_name":"Kidney cancer","level":3,"score":0.4422999918460846},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4316999912261963},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.39910000562667847},{"id":"https://openalex.org/C45235069","wikidata":"https://www.wikidata.org/wiki/Q278425","display_name":"Table (database)","level":2,"score":0.33649998903274536},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.31369999051094055},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.29409998655319214},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.2646999955177307},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.26080000400543213},{"id":"https://openalex.org/C2778653478","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Kidney disease","level":2,"score":0.2540999948978424},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.25110000371932983}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/2767-9764.30162532","doi":"https://doi.org/10.1158/2767-9764.30162532","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.30162532","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/30162532","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/Table_3_from_Prognostic_Impact_of_Immune-Related_Adverse_Events_on_Combination_Immune_Checkpoint_Tyrosine_Kinase_Inhibition_for_Metastatic_Renal_Cancer/30162532","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Dataset"}],"best_oa_location":{"id":"doi:10.1158/2767-9764.30162532","doi":"https://doi.org/10.1158/2767-9764.30162532","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.30162532","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4414366328","https://openalex.org/W4414366293","https://openalex.org/W4414366332","https://openalex.org/W4414366331","https://openalex.org/W4414366357","https://openalex.org/W4414366339","https://openalex.org/W4414016993","https://openalex.org/W4414366321","https://openalex.org/W4415691480","https://openalex.org/W4360606286"],"abstract_inverted_index":{"Patient":[0],"characteristics":[1],"of":[2],"the":[3],"ICI\u2013ICI":[4],"group.":[5]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2025-10-10T00:00:00"}